For research use only. Not for therapeutic Use.
Tesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD)[1].
| Catalog Number | I042208 |
| CAS Number | 2242758-08-1 |
| Purity | ≥95% |
| Reference | [1]. Kasper Vadstrup, et al. Anti-NKG2D mAb: A New Treatment for Crohn’s Disease? Int J Mol Sci. 2017 Sep 16;18(9):1997. |
